Thermo Fisher Scientific Inc (TMO)
Thermo Fisher Scientific Inc (TMO) carries a ŷRobot AI score of 53 out of 100. The model's fair value estimate is $694.05, 4.9% above the last close of $661.74. The chart signal reads Bearish.
| Metric | TMO |
|---|---|
| AI score | 53 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $694.05 |
| Upside to fair value | 4.9% |
| Previous close | $661.74 |
| P/E | 36.39 |
| Price / sales | 5.21 |
| Market cap | $250.23B |
| EPS | 18.55 |
| Revenue growth | -0.2% |
| 1-year price change | 4.3% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about TMO
Is TMO overvalued or undervalued right now?
As of Oct 7, 2026, ŷRobot's fair-value model estimates Thermo Fisher Scientific Inc (TMO) at $694.05 against a last close of $661.74, implying 4.9% upside to the model's estimate.
Is TMO's chart signal bullish or bearish?
The chart-signal model classifies TMO as Neutral as of Oct 7, 2026, with a signal score of -0.08 on a -1 to 1 scale.
What is TMO's ŷRobot AI score?
TMO scores 53 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 7, 2026.
Is TMO stock expensive on P/E and P/S?
TMO trades at 36.4 times earnings and 5.2 times sales as of Oct 7, 2026.
What does TMO's seasonal forecast show?
ŷRobot's seasonal forecast curve for TMO reads -0.7% at 30 days, +0.5% at 90 days, and +4.3% at one year as of Oct 7, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is TMO growing?
Thermo Fisher Scientific Inc's revenue growth is -0.2% and free-cash-flow growth is -0.7% on the latest reported figures.
TMO chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.